Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation

Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations. Methods Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from para...

Full description

Saved in:
Bibliographic Details
Published inJournal of international medical research Vol. 42; no. 5; pp. 1110 - 1117
Main Authors Zou, JianYong, Bella, Amos Ela, Chen, ZhenGuang, Han, XiangQian, Su, ChunHua, Lei, YiYan, Luo, HongHe
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.10.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations. Methods Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid. Results EGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE. Conclusions There was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE.
AbstractList Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations. Methods Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid. Results EGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE. Conclusions There was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE.
OBJECTIVEA retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations.METHODSPretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid.RESULTSEGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE.CONCLUSIONSThere was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE.
A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations. Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid. EGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE. There was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE.
Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations. Methods Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid. Results EGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE. Conclusions There was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE.
Author Zou, JianYong
Han, XiangQian
Su, ChunHua
Bella, Amos Ela
Chen, ZhenGuang
Luo, HongHe
Lei, YiYan
Author_xml – sequence: 1
  givenname: JianYong
  surname: Zou
  fullname: Zou, JianYong
– sequence: 2
  givenname: Amos Ela
  surname: Bella
  fullname: Bella, Amos Ela
– sequence: 3
  givenname: ZhenGuang
  surname: Chen
  fullname: Chen, ZhenGuang
– sequence: 4
  givenname: XiangQian
  surname: Han
  fullname: Han, XiangQian
– sequence: 5
  givenname: ChunHua
  surname: Su
  fullname: Su, ChunHua
– sequence: 6
  givenname: YiYan
  surname: Lei
  fullname: Lei, YiYan
– sequence: 7
  givenname: HongHe
  surname: Luo
  fullname: Luo, HongHe
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25239875$$D View this record in MEDLINE/PubMed
BookMark eNp1kU9rFTEUxYNU7Gvr3pVk6Wb0Jpl_cSelrxYKhWLXQya5M03JJM9koryP4rc1z1cFBVeBe8_5hXvOGTnxwSMhbxi8Z6zrPoAAgBYaVjdC8k68IBtWd6LiZX5CNod1ddifkrOUngBq3jb8FTnlDRey75oN-bGN-DWj13saJnp1vb2nS17VaoNP1Hrqsp-pMuiDVlFbHxZFv9v1kS7K2dkrv9KdwxyVozhNORXfR3qz7JzVvyAHqlZeY6SjDS7MZe7oiI_qmw050ohzdmpFQ8f9399fkJeTcglfP7_n5GF79eXyc3V7d31z-em20kJ0a8XMyLRkBjrgU9-DbMdGCy6MQi6aEgtAXzMxStmLVo7Qg55AMyPaCTtjenFO3h25uxhKEmkdFps0Oqc8hpwG1rRCyrrwixSOUh1DShGnYRftouJ-YDAcChn-LaRY3j7T87ig-WP43UARVEdBUjMOTyUTX679P_AnlS2V_w
CitedBy_id crossref_primary_10_1111_1759_7714_15210
crossref_primary_10_1097_MCP_0000000000000264
crossref_primary_10_18632_oncotarget_23686
crossref_primary_10_1007_s13665_018_0196_1
crossref_primary_10_1002_cam4_2458
crossref_primary_10_5761_atcs_oa_17_00088
crossref_primary_10_1016_j_jmoldx_2017_10_007
crossref_primary_10_3892_ol_2017_7195
crossref_primary_10_1177_2373997515616584
crossref_primary_10_1038_srep13574
crossref_primary_10_2217_fon_2016_0163
crossref_primary_10_1007_s12672_024_01094_x
crossref_primary_10_1186_s12885_022_09701_2
crossref_primary_10_1093_ejcts_ezaa394
Cites_doi 10.1146/annurev.me.41.020190.000255
10.1016/j.rmr.2011.03.005
10.1016/j.cell.2012.08.029
10.1183/09031936.00069812
10.1016/j.lungcan.2007.09.024
10.1183/09031936.00167407
10.1634/theoncologist.2011-0385
10.1378/chest.103.4_Supplement.385S
10.1097/JTO.0b013e31827ed0ff
10.1016/j.cllc.2011.02.006
10.1016/j.lungcan.2013.11.021
10.1016/j.ccm.2011.09.001
10.1097/JTO.0b013e318267223a
10.1038/nrclinonc.2011.126
10.1097/JTO.0b013e318168be93
10.1016/S0025-6196(11)60848-3
10.1016/j.lungcan.2010.12.009
10.1038/sj.bjc.6602296
10.1038/modpathol.2011.46
10.1016/j.lungcan.2007.02.016
10.1159/000338169
10.1016/0959-8049(95)00664-8
10.1200/JCO.2005.09.985
10.1007/s13402-012-0078-4
10.3322/caac.20107
10.3892/etm.2011.273
ContentType Journal Article
Copyright The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav
The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
Copyright_xml – notice: The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav
– notice: The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
DBID AFRWT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1177/0300060514539273
DatabaseName Sage Journals GOLD Open Access 2024
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: AFRWT
  name: Sage Journals GOLD Open Access 2024
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1473-2300
EndPage 1117
ExternalDocumentID 10_1177_0300060514539273
25239875
10.1177_0300060514539273
Genre Clinical Trial
Journal Article
GroupedDBID ---
.55
.GJ
01A
0R~
29K
2WC
44B
53G
54M
5GY
5RE
5VS
7X7
8FI
8FJ
AABQO
AACKU
AAGGD
AAJIQ
AAJOX
AAJPV
AAJQC
AAMGE
AANSI
AAPEO
AAQQG
AAQXH
AATBZ
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWP
ABDWY
ABHKI
ABJNI
ABNCE
ABPGX
ABQKF
ABQXT
ABUWG
ABVFX
ABXGC
ABYTW
ACARO
ACFMA
ACFYK
ACGBL
ACGFS
ACGZU
ACLHI
ACROE
ACSIQ
ACUIR
ADBBV
ADEIA
ADMPF
ADOGD
ADQSQ
ADTBJ
ADUKL
AECVZ
AEDTQ
AEFTW
AEKYL
AENEX
AERKM
AEUHG
AEUIJ
AEWDL
AEWHI
AEXFG
AFCOW
AFKBI
AFKRA
AFKRG
AFRWT
AIGRN
AIOMO
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
ALIPV
ALJHS
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AUTPY
AYAKG
BAWUL
BCNDV
BDDNI
BENPR
BFDSU
BPHCQ
BSEHC
BVXVI
CBRKF
CCPQU
CORYS
CQQTX
CUTAK
D-I
DC.
DF.
DF0
DIK
DO-
DV7
E3Z
EBD
EBS
EF0
EJD
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HMCUK
HYE
J8X
JCYGO
K.F
KQ8
L7B
MK0
O9-
OK1
P2P
PIMPY
PQQKQ
Q1R
ROL
RPM
S01
SFC
SV3
TR2
TUS
UKHRP
X7M
ZE2
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c337t-1db1c91d0702f88096b5c323dae235539008413b998369b080cf0c1d36fe7dd83
IEDL.DBID AFRWT
ISSN 0300-0605
IngestDate Fri Jun 28 10:51:54 EDT 2024
Wed Sep 11 13:45:10 EDT 2024
Sat Sep 28 08:15:37 EDT 2024
Tue Jul 16 20:39:17 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords EGFR mutation
malignant pleural effusion
Lung adenocarcinoma
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(http://www.uk.sagepub.com/aboutus/openaccess.htm).
The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c337t-1db1c91d0702f88096b5c323dae235539008413b998369b080cf0c1d36fe7dd83
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://journals.sagepub.com/doi/full/10.1177/0300060514539273?utm_source=summon&utm_medium=discovery-provider
PMID 25239875
PQID 1563994070
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1563994070
crossref_primary_10_1177_0300060514539273
pubmed_primary_25239875
sage_journals_10_1177_0300060514539273
PublicationCentury 2000
PublicationDate 20141000
2014-Oct
2014-10-00
20141001
PublicationDateYYYYMMDD 2014-10-01
PublicationDate_xml – month: 10
  year: 2014
  text: 20141000
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: England
PublicationTitle Journal of international medical research
PublicationTitleAlternate J Int Med Res
PublicationYear 2014
Publisher SAGE Publications
Publisher_xml – name: SAGE Publications
References Smits, Kummer, Hinrichs 2012; 35
Jemal, Bray, Center 2011; 61
Dela Cruz, Tanoue, Matthay 2011; 32
Wu, Gow, Yu 2008; 32
Froudarakis 2012; 83
Lynch 1993; 103
Wu, Yu, Tsai 2013; 41
Jung, Kim, Lee 2011; 2
Morgensztern, Waqar, Subramanian 2012; 7
Sakurada, Lara-Guerra, Liu 2008; 3
Sahn 1990; 41
Ruppert, Wislez, Poulot 2011; 28
Mok, Wu, Zhang 2009; 8
Gridelli, De Marinis, Di Maio 2011; 72
Heffner, Klein 2008; 83
Rami-Porta, Crowley, Goldstraw 2009; 15
Yang, Wu, Chan 2014; 83
Chiu, Shih, Tsai 2007; 57
Hirsch, Jänne, Eberhardt 2013; 8
Chen, Zhong, Zhang 2012; 17
Buccheri, Ferrigno, Tamburini 1996; 32A
Imielinski, Berger, Hammerman 2012; 150
Jänne, Engelman, Johnson 2005; 23
Han, Eom, Kim 2011; 12
Mok 2011; 8
Barlési, Tchouhadjian, Doddoli 2005; 92
Li, Shi, Liang 2008; 60
Wen, Fu, Zhang 2011; 24
bibr1-0300060514539273
bibr19-0300060514539273
bibr14-0300060514539273
Rami-Porta R (bibr28-0300060514539273) 2009; 15
bibr23-0300060514539273
bibr5-0300060514539273
bibr27-0300060514539273
bibr10-0300060514539273
bibr2-0300060514539273
bibr7-0300060514539273
bibr15-0300060514539273
bibr6-0300060514539273
bibr11-0300060514539273
bibr24-0300060514539273
bibr12-0300060514539273
bibr8-0300060514539273
bibr20-0300060514539273
bibr17-0300060514539273
bibr16-0300060514539273
bibr9-0300060514539273
bibr21-0300060514539273
bibr3-0300060514539273
bibr25-0300060514539273
bibr18-0300060514539273
bibr13-0300060514539273
Mok T (bibr4-0300060514539273) 2009; 8
bibr22-0300060514539273
bibr26-0300060514539273
References_xml – volume: 35
  start-page: 189
  year: 2012
  end-page: 196
  article-title: EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
  publication-title: Cell Oncol (Dordr)
  contributor:
    fullname: Hinrichs
– volume: 17
  start-page: 978
  year: 2012
  end-page: 985
  article-title: EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas
  publication-title: Oncologist
  contributor:
    fullname: Zhang
– volume: 60
  start-page: 183
  year: 2008
  end-page: 192
  article-title: Prognostic significance of pleural lavage cytology in patients with lung cancer: a meta-analysis
  publication-title: Lung Cancer
  contributor:
    fullname: Liang
– volume: 92
  start-page: 13
  year: 2005
  end-page: 14
  article-title: CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy
  publication-title: Br J Cancer
  contributor:
    fullname: Doddoli
– volume: 57
  start-page: 213
  year: 2007
  end-page: 221
  article-title: Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib
  publication-title: Lung Cancer
  contributor:
    fullname: Tsai
– volume: 41
  start-page: 1409
  year: 2013
  end-page: 1418
  article-title: Survival of lung adenocarcinoma patients with malignant pleural effusion
  publication-title: Eur Respir J
  contributor:
    fullname: Tsai
– volume: 7
  start-page: 1485
  year: 2012
  end-page: 1489
  article-title: Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer
  publication-title: J Thorac Oncol
  contributor:
    fullname: Subramanian
– volume: 72
  start-page: 3
  year: 2011
  end-page: 8
  article-title: Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: implications for clinical practice and open issues
  publication-title: Lung Cancer
  contributor:
    fullname: Di Maio
– volume: 8
  start-page: 661
  year: 2011
  end-page: 668
  article-title: Personalized medicine in lung cancer: what we need to know
  publication-title: Nat Rev Clin Oncol
  contributor:
    fullname: Mok
– volume: 103
  start-page: 385S
  year: 1993
  end-page: 389S
  article-title: Management of malignant pleural effusions
  publication-title: Chest
  contributor:
    fullname: Lynch
– volume: 8
  start-page: 227
  year: 2009
  end-page: 231
  article-title: A small step towards personalized medicine for non-small cell lung cancer
  publication-title: Discov Med
  contributor:
    fullname: Zhang
– volume: 32A
  start-page: 1135
  year: 1996
  end-page: 1141
  article-title: Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution
  publication-title: Eur J Cancer
  contributor:
    fullname: Tamburini
– volume: 12
  start-page: 380
  year: 2011
  end-page: 386
  article-title: EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases
  publication-title: Clin Lung Cancer
  contributor:
    fullname: Kim
– volume: 41
  start-page: 7
  year: 1990
  end-page: 13
  article-title: The pathophysiology of pleural effusions
  publication-title: Annu Rev Med
  contributor:
    fullname: Sahn
– volume: 23
  start-page: 3227
  year: 2005
  end-page: 3234
  article-title: Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology
  publication-title: J Clin Oncol
  contributor:
    fullname: Johnson
– volume: 28
  start-page: 565
  year: 2011
  end-page: 577
  article-title: A simple view on lung cancer biology: the EGFR pathway
  publication-title: Rev Mal Respir
  contributor:
    fullname: Poulot
– volume: 32
  start-page: 605
  year: 2011
  end-page: 644
  article-title: Lung cancer: epidemiology, etiology, and prevention
  publication-title: Clin Chest Med
  contributor:
    fullname: Matthay
– volume: 83
  start-page: 235
  year: 2008
  end-page: 250
  article-title: Recent advances in the diagnosis and management of malignant pleural effusions
  publication-title: Mayo Clin Proc
  contributor:
    fullname: Klein
– volume: 61
  start-page: 69
  year: 2011
  end-page: 90
  article-title: Global cancer statistics
  publication-title: CA Cancer J Clin
  contributor:
    fullname: Center
– volume: 83
  start-page: 367
  year: 2012
  end-page: 376
  article-title: Pleural effusion in lung cancer: more questions than answers
  publication-title: Respiration
  contributor:
    fullname: Froudarakis
– volume: 8
  start-page: 373
  year: 2013
  end-page: 384
  article-title: Epidermal growth factor receptor inhibition in lung cancer: status 2012
  publication-title: J Thorac Oncol
  contributor:
    fullname: Eberhardt
– volume: 150
  start-page: 1107
  year: 2012
  end-page: 1120
  article-title: Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
  publication-title: Cell
  contributor:
    fullname: Hammerman
– volume: 3
  start-page: 527
  year: 2008
  end-page: 529
  article-title: Tissue heterogeneity of EGFR mutation in lung adenocarcinoma
  publication-title: J Thorac Oncol
  contributor:
    fullname: Liu
– volume: 15
  start-page: 4
  year: 2009
  end-page: 9
  article-title: The revised TNM staging system for lung cancer
  publication-title: Ann Thorac Cardiovasc Surg
  contributor:
    fullname: Goldstraw
– volume: 24
  start-page: 932
  year: 2011
  end-page: 943
  article-title: Genetic and epigenetic changes in lung carcinoma and their clinical implications
  publication-title: Mod Pathol
  contributor:
    fullname: Zhang
– volume: 2
  start-page: 685
  year: 2011
  end-page: 693
  article-title: Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib
  publication-title: Exp Ther Med
  contributor:
    fullname: Lee
– volume: 83
  start-page: 174
  year: 2014
  end-page: 181
  article-title: Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS)
  publication-title: Lung Cancer
  contributor:
    fullname: Chan
– volume: 32
  start-page: 924
  year: 2008
  end-page: 930
  article-title: Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma
  publication-title: Eur Respir J
  contributor:
    fullname: Yu
– ident: bibr20-0300060514539273
  doi: 10.1146/annurev.me.41.020190.000255
– ident: bibr8-0300060514539273
  doi: 10.1016/j.rmr.2011.03.005
– ident: bibr15-0300060514539273
  doi: 10.1016/j.cell.2012.08.029
– ident: bibr23-0300060514539273
  doi: 10.1183/09031936.00069812
– volume: 8
  start-page: 227
  year: 2009
  ident: bibr4-0300060514539273
  publication-title: Discov Med
  contributor:
    fullname: Mok T
– ident: bibr19-0300060514539273
  doi: 10.1016/j.lungcan.2007.09.024
– ident: bibr22-0300060514539273
  doi: 10.1183/09031936.00167407
– ident: bibr18-0300060514539273
  doi: 10.1634/theoncologist.2011-0385
– ident: bibr21-0300060514539273
  doi: 10.1378/chest.103.4_Supplement.385S
– ident: bibr3-0300060514539273
  doi: 10.1097/JTO.0b013e31827ed0ff
– ident: bibr26-0300060514539273
  doi: 10.1016/j.cllc.2011.02.006
– ident: bibr14-0300060514539273
  doi: 10.1016/j.lungcan.2013.11.021
– ident: bibr1-0300060514539273
  doi: 10.1016/j.ccm.2011.09.001
– ident: bibr9-0300060514539273
  doi: 10.1097/JTO.0b013e318267223a
– volume: 15
  start-page: 4
  year: 2009
  ident: bibr28-0300060514539273
  publication-title: Ann Thorac Cardiovasc Surg
  contributor:
    fullname: Rami-Porta R
– ident: bibr6-0300060514539273
  doi: 10.1038/nrclinonc.2011.126
– ident: bibr17-0300060514539273
  doi: 10.1097/JTO.0b013e318168be93
– ident: bibr10-0300060514539273
  doi: 10.1016/S0025-6196(11)60848-3
– ident: bibr5-0300060514539273
  doi: 10.1016/j.lungcan.2010.12.009
– ident: bibr13-0300060514539273
  doi: 10.1038/sj.bjc.6602296
– ident: bibr16-0300060514539273
  doi: 10.1038/modpathol.2011.46
– ident: bibr12-0300060514539273
  doi: 10.1016/j.lungcan.2007.02.016
– ident: bibr25-0300060514539273
  doi: 10.1159/000338169
– ident: bibr27-0300060514539273
  doi: 10.1016/0959-8049(95)00664-8
– ident: bibr7-0300060514539273
  doi: 10.1200/JCO.2005.09.985
– ident: bibr24-0300060514539273
  doi: 10.1007/s13402-012-0078-4
– ident: bibr2-0300060514539273
  doi: 10.3322/caac.20107
– ident: bibr11-0300060514539273
  doi: 10.3892/etm.2011.273
SSID ssj0042652
Score 2.207465
Snippet Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor...
A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor...
Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor...
OBJECTIVEA retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor...
SourceID proquest
crossref
pubmed
sage
SourceType Aggregation Database
Index Database
Publisher
StartPage 1110
SubjectTerms Adenocarcinoma - genetics
Adenocarcinoma - pathology
Adult
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - pathology
DNA Mutational Analysis
Female
Follow-Up Studies
Humans
Lung Neoplasms - genetics
Lung Neoplasms - pathology
Male
Middle Aged
Mutation - genetics
Neoplasm Staging
Pleural Effusion, Malignant - genetics
Pleural Effusion, Malignant - pathology
Polymerase Chain Reaction
Prognosis
Receptor, Epidermal Growth Factor - genetics
Retrospective Studies
Title Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation
URI https://journals.sagepub.com/doi/full/10.1177/0300060514539273
https://www.ncbi.nlm.nih.gov/pubmed/25239875
https://search.proquest.com/docview/1563994070
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBbp5tJL6bvbpGEKZaEQN7ZlSeteSgjrpoWWEDY0NyPLUgjE3uBdH_xT8m8zs7K7bEOgFx-MkYxnPPPNQ98w9imNtIykNYFNpA0SDDGCNJkWgabR0U5aGTo6O_zrtzy9SH5eissdVg9nYfovuPxCbVX4RmtjTX83ZaOP-iLjEWomEYmgsxfo3xX_1q6q3Ge7h6EadIfK021FlW1D_ZBdMJxue8J2YzWVYsR2j7PzP_PBdqO7En3dgcaxhGJT2Hyw57Yje4BOtzrD1s4qe86e9SgTjr1avGA7tn7JJmeepro7hPnm1NXyECZwtiGw7l6xu6zxDdYdLBzMvmfnULW-ZL-E6xpu0ECARoOFfrAx1_Wi0kD5XKgQ1F9RZw3c3lji8wDrXEv5uK_wY9O6Tqsa0rYGPAcUKQr0hAFtA429oqFitoSi297-NbvIZvOT06Af4RAYztUqiMoiMmlUomGJHZqKVBbC8JiX2saIdHhKfP4RLzDo4zItEL4aF5qo5NJZVZZT_oaN6kVt3zHQiS2UEhg4C56o2GqXOAy_dKKIZUCWY_Z5kEd-65k68mggM_9HdmP2cRBYjr8T1Uh0bRftMseVELJhlBuO2Vsvyb-rxYLIEpUYswmJNh909dFt3v_vg3vsKQKxxDcJ7rPRqmntBwQ7q-Kg19CDdbIAr7MsvAc_QvqA
link.rule.ids 315,783,787,867,21977,21978,27865,27936,27937,44957,45066,45345,45454
linkProvider SAGE Publications
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9NADLZG9zBeELABhQFGmiohLajJ_ciytwktdGObpqkTe4suyR2atKZT2jz0T-G_xe4lK2VC4i0PkS-Kz_bns-8zwF4SGh1qWwRWahtISjGCRB7kgeHR0U5bPXR8d_j8Qo-u5emNuvlj1Ff7B2dfuK2KvmjprB-sm5mSxJJDhOK8otAeiyewSU9S9WDzKL36Me7cMEUe1ZYQeLLKUK1qlI9krMekR0BzrclrGXfS5_CsBYx45DX8AjZs9RIGl55xerGP49UFqtk-DvByxUW92IZfae17pRc4dXj8Lb3CSeOr7zO8rfCObB0N-R4KaXVxW00nBvloFieEz39ykwze31mm5kDrXMNHa4d4supCZ6kFb5waPZ0T6xzbu_9NjbUfdW9LzBfry-_AdXo8_joK2mkMQSFEPA_CMg-LJCzJR0SOrD7RuSpEJEpjIwItImFq_lDklL8JneSERAs3LMJSaGfjsjwQr6BXTSv7BtBIm8exohyYNBdH1jjpKJMyMmbCAF324XOnj-zek25kYcdL_pfu-vCpU1hGlsHlDlPZaTPLSBKhL0pYh3147TX5IC1SzHsYqz4MWLVZt-3-uczb_33xI2yNxudn2dnJxfd38JTwlfS9f7vQm9eNfU8YZp5_aHfrb7585hE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9xADBZtAqWXkj6zfapQFgpxs_Y8HPcW2rhJH2EJG5qbGXtmSiDrXbzrw_6U_NtKGbvLNhR6N7KxRtKnkfQJ4F0WGx1rV0VOahdJSjGiTB6UkeHV0V47PfI8O_zjVB-fy68X6qLrzeFZmO4PLj5wWxV90Y2zZuueW7_f1Rj36WAyjwjFekXhPRV3YVsS0Kfca_swP_s56V0xRR_VlRF4u8pIreuUt2RsxqVbYHOj0esm9uQ78KADjXgYtPwQ7rj6EQzHgXV6tYeT9RDVYg-HOF7zUa8ew3XehH7pFc48Hn3Jz3Dahgr8Ai9rvCJ7R0P-h8JaU13Ws6lBvp7FKWH0X9wog_Mrx_Qc6Lxv-XrtI56sO9FZasWHp8FA6cR6x27-v22wCevuncVytfn6J3CeH00-HUfdRoaoEiJdRrEt4yqLLfmJxJPlZ7pUlUiENS4h4CIypuePRUk5nNBZSWi08qMqtkJ7l1p7IJ7CVj2r3S6gka5MU0V5sBIyTZzx0lM2ZWTKpAHaDuB9r49iHog3irjnJv9LdwN42yusIOvgkoep3axdFCSJEBglraMBPAua_CMtUcx9mKoBDFm1RX_0_vma5__74Bu4N_6cF99PTr-9gPsEsWRo_3sJW8umda8IxizL191h_Q1aZecq
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Frequency+of+EGFR+mutations+in+lung+adenocarcinoma+with+malignant+pleural+effusion%3A+Implication+of+cancer+biological+behaviour+regulated+by+EGFR+mutation&rft.jtitle=Journal+of+international+medical+research&rft.au=Zou%2C+JianYong&rft.au=Bella%2C+Amos+Ela&rft.au=Chen%2C+ZhenGuang&rft.au=Han%2C+XiangQian&rft.date=2014-10-01&rft.eissn=1473-2300&rft.volume=42&rft.issue=5&rft.spage=1110&rft_id=info:doi/10.1177%2F0300060514539273&rft_id=info%3Apmid%2F25239875&rft.externalDocID=25239875
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-0605&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-0605&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-0605&client=summon